Cart
sales@molnova.com
(±)-AC 7954 hydrochloride
CAS No. 477313-09-0
(±)-AC 7954 hydrochloride( —— )
Catalog No. M33818 CAS No. 477313-09-0
(±)-AC 7954 hydrochloride is a urotensin-II (UT) receptor activator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 125 | Get Quote |
|
| 5MG | 188 | Get Quote |
|
| 10MG | 278 | Get Quote |
|
| 25MG | 455 | Get Quote |
|
| 50MG | 664 | Get Quote |
|
| 100MG | 888 | Get Quote |
|
| 500MG | 1782 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(±)-AC 7954 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief Description(±)-AC 7954 hydrochloride is a urotensin-II (UT) receptor activator.
-
DescriptionAC-7954 is a selective nonpeptidic urotensin receptor agonist (EC50: 300 nM at the human UII receptor).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetNeurotensin Receptor
-
RecptorNeurotensin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number477313-09-0
-
Formula Weight366.28
-
Molecular FormulaC19H21Cl2NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.O=C1OC(C2=CC=C(Cl)C=C2)(CC=3C=CC=CC13)CCN(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Croston GE, et al. Discovery of the first nonpeptide agonist of the GPR14/urotensin-II receptor: 3-(4-chlorophenyl)-3-(2- (dimethylamino)ethyl)isochroman-1-one (AC-7954). J Med Chem. 2002 Nov 7;45(23):4950-3.?
molnova catalog
related products
-
SB 611812
SB 611812 is an antagonist of urotensin-II (UT) and can be used in studies about the treatment of cardiovascular disease.
-
SR 142948
SR 142948 is a neurotensin (NT) receptor antagonist.
-
JMV 449
Potent, metabolically stable neurotensin receptor agonist peptide (IC50 = 0.15 nM for inhibition of [125I]-NT binding to neonatal mouse brain; EC50 = 1.9 nM for contraction of guinea pig ileum). Produces long-lasting hypothermic, neuroprotective and analgesic effects in mice following central administration in vivo.
